pentobarbital will reduce the level or result of buprenorphine buccal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will decrease the extent or influence of disopyramide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Mysterious.
pentobarbital will lower the extent or outcome of abiraterone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will minimize the extent or impact of losartan by impacting hepatic enzyme CYP2C9/10 metabolism. Slight/Significance Not known.
Constantly observe vital signs throughout sedation and recovery period if coadministered. Very carefully titrate remimazolam dose if administered with opioid analgesics and/or sedative/hypnotics.
pentobarbital will decrease the extent or result of iloperidone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
Stay away from; coadministration with CYP3A inducers may possibly result in reduced plasma concentrations of elvitegravir and/or perhaps a concomitantly administered protease inhibitor and bring on lack of therapeutic outcome also to achievable resistance
pentobarbital will lessen the level or effect of pazopanib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will minimize the extent or result of sunitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
This drug may well interfere with the absorption of orally administered griseofulvin, reducing its blood stages; effects of blood amount reduction unfamiliar; preferable to prevent concomitant administration of these drugs
Warning with use all through surgeries or methods in kids youthful than three yr or in pregnant Ladies during their third trimester
pentobarbital will lower the level or result of atorvastatin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will decrease the extent or effect of lumacaftor/ivacaftor by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
pentobarbital will reduce the level or outcome of fostemsavir by website impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.